Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform

Lancet Oncol. 2022 Feb;23(2):198-201. doi: 10.1016/S1470-2045(21)00707-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Health Services Accessibility*
  • Humans
  • Netherlands

Substances

  • Antineoplastic Agents